C. Hoke

发表

Molecular and epidemiologic analysis of dengue virus isolates from Somalia.

G. Chang, A. Magill, N. Kanesa-thasan, 1998, Emerging infectious diseases.

Identification of hepatitis E virus in clinical specimens: amplification of hydroxyapatite-purified virus RNA and restriction endonuclease analysis.

V. Gouvea, B. Innis, K. Myint, 1997, Journal of virological methods.

Partnerships for detecting emerging infectious diseases: Nepal and global influenza surveillance.

D. Vaughn, N. Cox, P. Kelley, 1998, Emerging infectious diseases.

Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates

H. Sumiyoshi, D. Trent, C. Hoke, 1992, Journal of virology.

Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine.

C. Hoke, L. Binn, E. D'Hondt, 1992, Vaccine.

Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells.

K. Porter, C. Hayes, E. Henchal, 1997, The Journal of general virology.

Infectious diseases investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. military.

D. Vaughn, W. N. Burnette, T. Palys, 2008, Military medicine.

Immunization of US soldiers with a two-dose primary series of inactivated hepatitis A vaccine: early immune response, persistence of antibody, and response to a third dose at 1 year.

B. Feighner, R. DeFraites, M. Krauss, 1995, The Journal of infectious diseases.

Japanese encephalitis virus in Bangkok: factors influencing vector infections in three suburban communities.

A. Nisalak, J. Sattabongkot, J. Latendresse, 1992, Journal of medical entomology.

History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system.

C. Hoke, Clifford E Snyder, 2013, Vaccine.

Fatal outcome in Japanese encephalitis.

A. Nisalak, D. Burke, C. Leake, 1985, The American journal of tropical medicine and hygiene.

History of U.S. military contributions to the study of viral encephalitis.

C. Hoke, 2005, Military medicine.

Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers.

D. Vaughn, S. Yoksan, B. Innis, 1996, Vaccine.

Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers.

W. Bancroft, R. M. Scott, C. Hoke, 1984, The Journal of infectious diseases.

Japanese encephalitis: Immunocytochemical studies of viral antigen and Inflammatory cells in fatal cases

A. Nisalak, C. Leake, C. Hoke, 1985, Annals of neurology.

T cell activation in vivo by dengue virus infection.

F. Ennis, I. Kurane, A. Meager, 1995, Journal of clinical & laboratory immunology.

Swine-Influenza Infection in Civilians

R. Wenzel, M. Sande, J. Gwaltney, 1976 .

Swine-influenza infection in civilians. Report of two cases.

R. Wenzel, M. Sande, R. L. Thompson, 1976, The New England journal of medicine.

PANDEMIC INFLUENZA AND THE SWINE INFLUENZA VIRUS 1

W. Dowdle, R. O'brien, C. Hoke, 2003 .

Pandemic influenza and the swine influenza virus.

W. Dowdle, R. O'brien, C. Hoke, 1976, Bulletin of the Pan American Health Organization.

US Military contributions to the global response to pandemic chikungunya.

D. Vaughn, Pamela J. Glass, F. Malinoski, 2012, Vaccine.

Predictive value of surveillance case definitions of Guillain-Barré Syndrome in vaccine safety assessment.

A. Hawksworth, R. Engler, C. Hoke, 2012, MSMR.

Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humans.

W. Bancroft, R. M. Scott, F. Malinoski, 1990, The American journal of tropical medicine and hygiene.

Virus isolations from mosquitoes collected during the 1982 Japanese encephalitis epidemic in northern Thailand.

D. Burke, C. Leake, A. Nisalak, 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.

A longitudinal study of Japanese encephalitis in suburban Bangkok, Thailand.

A. Nisalak, J. Latendresse, C. Hoke, 1987, The Southeast Asian journal of tropical medicine and public health.

Dengue fever in US military personnel in Haiti.

R. DeFraites, A. King, N. Kanesa-thasan, 1997, JAMA.

A model international partnership for community-based research on vaccine-preventable diseases: the Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU).

A. Nisalak, D. Vaughn, D. Burke, 2013, Vaccine.

eview model international partnership for community-based research on accine-preventable diseases : The Kamphaeng Phet-AFRIMS Virology esearch Unit ( KAVRU )

M. Mammen, C. Hoke, Bruce L. Innise, 2013 .

Protection against Japanese encephalitis by inactivated vaccines.

A. Nisalak, J. Latendresse, S. Jatanasen, 1988, The New England journal of medicine.

Estimated global incidence of Japanese encephalitis: a systematic review.

S. Hills, T. Solomon, J. Hombach, 2011, Bulletin of the World Health Organization.

The epidemiology of Japanese encephalitis: prospects for prevention.

D. Vaughn, C. Hoke, 1992, Epidemiologic reviews.

Isolation of Japanese encephalitis virus from clinical specimens using a continuous mosquito cell line.

A. Nisalak, D. Burke, C. Leake, 1986, The American journal of tropical medicine and hygiene.

Improved surveillance of Japanese encephalitis by detection of virus-specific IgM in desiccated blood specimens.

D. Burke, A. Nisalak, C. Hoke, 1985, Bulletin of the World Health Organization.

An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.

A. Nisalak, B. Innis, S. Nimmannitya, 1989, The American journal of tropical medicine and hygiene.

Leishmaniasis in the United States military.

J. Berman, A. Magill, N. Aronson, 1998, Military medicine.

Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys.

J. Sadoff, R. Putnak, C. Hoke, 1996, The Journal of infectious diseases.

Immunogenic and protective response in mice immunized with a purified, inactivated, Dengue-2 virus vaccine prototype made in fetal rhesus lung cells.

Tran Truong, R. Putnak, C. Hoke, 1996, The American journal of tropical medicine and hygiene.

False-positive Gram-stained smears.

R. L. Cox, L. Reller, S. Mirrett, 1979, JAMA.

Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine.

M. Cochran, E. Henchal, R. Putnak, 1990, The American journal of tropical medicine and hygiene.

Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.

D. Burke, P. Mason, J. Dalrymple, 1989, The Journal of general virology.

Hepatitis A in the US Army: epidemiology and vaccine development.

R. DeFraites, B. Innis, C. Hoke, 1992, Vaccine.

Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus.

A. Nisalak, D. Vaughn, R. Johnson, 1992, The Journal of infectious diseases.

Epidémiologie de l'hépatite A

H. Margolis, M. Alter, P. Vandamme, 1992 .

A cluster of acute hepatitis E infection in United Nations Bangladeshi peacekeepers in Haiti.

J. Drabick, J. Gambel, V. Gouvea, 1997, The American journal of tropical medicine and hygiene.

Infection of owl monkeys (Aotus trivirgatus) and cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus from Mexico.

J. Ticehurst, J. Leduc, L. Rhodes, 1992, The Journal of infectious diseases.

Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.

W. Bancroft, Y. Lerman, D. Cohen, 1993, The Journal of infectious diseases.

Initial assessment of impact of adenovirus type 4 and type 7 vaccine on febrile respiratory illness and virus transmission in military basic trainees, March 2012.

A. Hawksworth, C. Hoke, Charles H Hoke, 2012, MSMR.

Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999.

Donald S Burke, A. Nisalak, D. Vaughn, 2003, The American journal of tropical medicine and hygiene.

Functional and antigenic domains of the dengue-2 virus nonstructural glycoprotein NS-1.

K. Irie, D. Burke, P. Charles, 1988, Virology.

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.

E. Konishi, D. Vaughn, P. Mason, 2000, Vaccine.

Rapid diagnosis of rabies and post-vaccinal encephalitides.

D. Burke, N. White, D. Warrell, 1988, Clinical and experimental immunology.

Anti-rabies virus IgM in serum and cerebrospinal fluid from rabid dogs.

D. Burke, M. Elwell, G. Ward, 1986, The Southeast Asian journal of tropical medicine and public health.

Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus.

D. Vaughn, B. Innis, B. Raengsakulrach, 1999, The American journal of tropical medicine and hygiene.

Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection.

C. Hoke, J. R. Putnak, R. Warren, 1995, Vaccine.

Japanese encephalitis vaccine (inactivated, BIKEN) in U.S. soldiers: immunogenicity and safety of vaccine administered in two dosing regimens.

N. Karabatsos, C. Meschievitz, Jose L. Sanchez, 1999, The American journal of tropical medicine and hygiene.

Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series.

N. Karabatsos, C. Meschievitz, R. DeFraites, 1995, The Journal of infectious diseases.

Dengue serotypes 2 and 3 in US forces In Somalia

D. Vaughn, A. Magill, N. Kanesa-thasan, 1994, The Lancet.

Further experience with Japanese encephalitis vaccine

R. DeFraites, José L. Sanchez, L. Pang, 1990, The Lancet.

Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys.

A. Nisalak, D. Vaughn, B. Innis, 1999, The American journal of tropical medicine and hygiene.

An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys.

A. Nisalak, D. Vaughn, B. Innis, 1999, The American journal of tropical medicine and hygiene.

The declining transmission of hepatitis A in Thailand.

B. Innis, C. Hoke, R. Snitbhan, 1991, The Journal of infectious diseases.

Sensitivity and specificity of a universal primer set for the rapid diagnosis of dengue virus infections by polymerase chain reaction and nucleic acid hybridization.

V. Vorndam, B. Innis, E. Henchal, 1991, The American journal of tropical medicine and hygiene.

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.

D. Vaughn, J. Saluzzo, B. Innis, 2001, Vaccine.

Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine.

D. Vaughn, F. Ennis, S. Yoksan, 1994, Journal of Infectious Diseases.

Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.

A. Nisalak, F. Ennis, I. Kurane, 1989, The Journal of clinical investigation.

Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate.

R. Purcell, J. Ticehurst, E. D'hondt, 1992, Vaccine.

Immunogenicity of an inactivated hepatitis A vaccine.

W. Bancroft, W. Lednar, J. Ticehurst, 1991, Annals of internal medicine.

Epidemiology of Hepatitis E Virus (HEV): A Cohort Study in Kathmandu, Nepal

J. Ticehurst, B. Innis, M. P. Shrestha, 1994 .

Blood value changes in flavivirus-inoculated Macaca fascicularis monkeys.

A. Nisalak, S. Yoksan, E. Henchal, 1986, Southeast Asian Journal of Tropical Medicine and Public Health.

Quantitative relationship between oral temperature and severity of illness following inoculation with candidate attenuated dengue virus vaccines.

P. Mackowiak, D. Vaughn, C. Tacket, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates.

E. Konishi, F. Ennis, P. Mason, 1998, Vaccine.

Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines.

D. Vaughn, C. Tacket, R. Edelman, 2003, The American journal of tropical medicine and hygiene.

Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates.

R. Edelman, B. Innis, A. King, 2003, The American journal of tropical medicine and hygiene.

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.

D. Vaughn, C. Tacket, R. Edelman, 1994, The Journal of infectious diseases.

Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.

D. Vaughn, B. Innis, E. Henchal, 2003, The American journal of tropical medicine and hygiene.

Genotyping of hepatitis E virus in clinical specimens by restriction endonuclease analysis.

V. Gouvea, B. Innis, C. Hoke, 1998, Journal of virological methods.

Hepatitis E virus in Nepal: similarities with the Burmese and Indian variants.

D. Vaughn, V. Gouvea, B. Innis, 1997, Virus research.

Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge.

C. Hackett, R. Putnak, C. Hoke, 1991, The American journal of tropical medicine and hygiene.

Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination

D. Vaughn, S. Green, F. Ennis, 1993, Journal of virology.

Administration of hepatitis A vaccine to a military population by needle and jet injector and with hepatitis B vaccine.

R. DeFraites, J. Sánchez, C. Hoke, 1995, The Journal of infectious diseases.

Comparison of sevral wild-type influenza viruses in the ferret tracheal organ culture system.

S. Mostow, G. Meiklejohn, C. Hoke, 1979, Reviews of infectious diseases.

Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series.

N. Karabatsos, C. Meschievitz, R. DeFraites, 1995, The Journal of infectious diseases.

Field trial of a Japanese encephalitis diagnostic kit

A. Nisalak, C. Hoke, D. Burke, 1986, Journal of medical virology.

Induction of lactogenic immunity to transmissible gastroneteritis virus of swine using an attenuated coronavirus mutant able to survive in the physicochemical environment of the digestive tract

Manfred S. Green, Y. Lerman, D. Cohen, 1991, Veterinary Microbiology.